PGI-Chandigarh among 17 trial sites for Oxford vaccine
The PGI Hospital here is among the 17 trial sites in India for conducting the second and third phases of human clinical trials of Covishield, the potential vaccine developed by Oxford University, its director said on Tuesday. The trials would involve administration of the vaccine to 1,600 healthy adults across 17 sites. Postgraduate Institute of … Read more PGI-Chandigarh among 17 trial sites for Oxford vaccine